People taking weight-loss drugs… including popular GLP-1s … may regain a significant amount of weight within months of ...

For patients with type 2 diabetes, GLP-1 RAs are associated with an increased risk for GERD and its complications compared with SGLT-2 inhibitors.

Estimated risk ratio was lower with GLP-1 receptor agonists for those younger than 75 years, but was no different for those aged 75 years or older ...

Company to Host Pre-Eminent Lap-Band® Surgeon Advocates For a Three-Day Seminar, August 1-3, 2025 ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

Gilles Andrier, CEO of Givaudan discusses HY earnings, and outlines areas of growth within the business despite ongoing ...

Low rates of retained gastric contents were seen in endoscopy patients on GLP-1 receptor agonists ( RAs), a retrospective ...

The money will focus on a manufacturing plant in Virginia that will make the company's weight management and metabolic drugs ...

For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using ...

Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, discusses the importance ...

It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...

Survey by PCRM reveals confusion about weight loss drugs, with interest in plant-based diets as safer alternative.